A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis
2022
Yuta Norimatsu | Yurie Norimatsu
We present a case of deep dermatomycosis caused by Trichophyton rubrum that developed after administration of SARS-CoV-2 BNT162b2 vaccination.A 75-year-old man was vaccinated with SARS-CoV-2 on day 0 and day 23. From day 25, pustules began to appear.A skin biopsy was performed. Tissue culture revealed the presence of Trichophyton rubrum.The patient was treated with topical luliconazole and 100 mg/day oral fosravuconazole for 84 days, after which the symptoms resolved.
显示更多 [+] 显示较少 [-]书目信息
出版者
Elsevier
其它主题
Dermatomycosis; Pustular psoriasis; Sars-cov-2 vaccination; Bnt162b2; Fosravuconazole; Trichophyton rubrum
语言
英语
2024-12-12
2026-02-03
DOAJ